Barclays’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-596
Closed -$1K 5424
2020
Q4
$1K Sell
596
-233,706
-100% -$569K ﹤0.01% 4843
2020
Q3
$737K Sell
234,302
-13,622
-5% -$43.5K ﹤0.01% 2939
2020
Q2
$720K Buy
247,924
+27,203
+12% +$86K ﹤0.01% 3042
2020
Q1
$623K Buy
220,721
+105,794
+92% +$341K ﹤0.01% 3409
2019
Q4
$372K Sell
114,927
-157,472
-58% -$457K ﹤0.01% 4546
2019
Q3
$588K Buy
272,399
+82,305
+43% +$220K ﹤0.01% 4116
2019
Q2
$598K Buy
190,094
+55,904
+42% +$181K ﹤0.01% 4164
2019
Q1
$500K Buy
134,190
+23,649
+21% +$79.8K ﹤0.01% 4124
2018
Q4
$321K Sell
110,541
-302,528
-73% -$831K ﹤0.01% 4225
2018
Q3
$1.08M Buy
413,069
+293,071
+244% +$719K ﹤0.01% 3542
2018
Q2
$280K Buy
119,998
+51,253
+75% +$143K ﹤0.01% 4439
2018
Q1
$202K Buy
68,745
+7,246
+12% +$19.8K ﹤0.01% 4823
2017
Q4
$168K Buy
61,499
+30,000
+95% +$92.2K ﹤0.01% 4835
2017
Q3
$107K Buy
31,499
+16,831
+115% +$46.8K ﹤0.01% 4885
2017
Q2
$36K Sell
14,668
-42,588
-74% -$98K ﹤0.01% 5527
2017
Q1
$131K Sell
57,256
-53,588
-48% -$119K ﹤0.01% 4689
2016
Q4
$235K Buy
110,844
+90,818
+454% +$253K ﹤0.01% 4086
2016
Q3
$66K Sell
20,026
-423
-2% -$1.34K ﹤0.01% 4816
2016
Q2
$64K Sell
20,449
-84,834
-81% -$283K ﹤0.01% 4708
2016
Q1
$316K Buy
105,283
+72,851
+225% +$227K ﹤0.01% 3511
2015
Q4
$98K Sell
32,432
-147,160
-82% -$616K ﹤0.01% 4415
2015
Q3
$899K Sell
179,592
-3,493
-2% -$20K ﹤0.01% 2831
2015
Q2
$1.1M Buy
183,085
+10,036
+6% +$67.2K ﹤0.01% 2803
2015
Q1
$1.21M Sell
173,049
-34,438
-17% -$249K ﹤0.01% 2796
2014
Q4
$1.45M Buy
207,487
+5,767
+3% +$45.6K ﹤0.01% 2821
2014
Q3
$1.41M Sell
201,720
-944
-0.5% -$8.76K ﹤0.01% 3002
2014
Q2
$1.82M Buy
202,664
+164,003
+424% +$1.46M ﹤0.01% 2701
2014
Q1
$309K Buy
38,661
+23,076
+148% +$198K ﹤0.01% 4374
2013
Q4
$126K Buy
15,585
+5,649
+57% +$47.6K ﹤0.01% 5444
2013
Q3
$70K Sell
9,936
-5,440
-35% -$43.7K ﹤0.01% 5877
2013
Q2
$119K Buy
+15,376
New +$120K ﹤0.01% 5651

Other funds holding PDLI